Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Early developments in combination therapy.

D L Scott1, S Farrow, S I Yeo

  • 1Department of Rheumatology, Guy's, King's and St. Thomas' School of Medicine, King's College, London, UK.

Clinical and Experimental Rheumatology
|December 10, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and evaluation of a high-fidelity, multi-disciplinary simulation training course for high-consequence infectious diseases using fluorescence visualization.

The Journal of hospital infection·2024
Same author

A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis.

Arthritis research & therapy·2020
Same author

Secular changes in functional disability, pain, fatigue and mental well-being in early rheumatoid arthritis. A longitudinal meta-analysis.

Seminars in arthritis and rheumatism·2019
Same author

Scientific Business Abstracts of the 112th Annual Meeting of the Association of Physicians of Great Britain and Ireland.

QJM : monthly journal of the Association of Physicians·2019
Same author

The frequency of remission and low disease activity in patients with rheumatoid arthritis, and their ability to identify people with low disability and normal quality of life.

Seminars in arthritis and rheumatism·2019
Same author

Impact of intensive treatment and remission on health-related quality of life in early and established rheumatoid arthritis.

RMD open·2016
Same journal

The expanded cardiovascular risk prediction score as a cardiovascular mortality predictor in rheumatoid arthritis.

Clinical and experimental rheumatology·2026
Same journal

Rising overweight and obesity in Swiss psoriatic arthritis patients, 2007-2022: a nationwide registry-population comparison.

Clinical and experimental rheumatology·2026
Same journal

Clinical features and gastrointestinal bleeding risk factors in IgA vasculitis patients: a retrospective study in a large volume centre.

Clinical and experimental rheumatology·2026
Same journal

Reply to the comment on: The microbiota in axial spondyloarthritis: what have we learned from Mendelian randomisation studies?

Clinical and experimental rheumatology·2026
Same journal

Comprehensive evaluation of bone structural and microarchitectural changes in rheumatoid arthritis treated with baricitinib using HR-pQCT, imaging, and biomarker analyses.

Clinical and experimental rheumatology·2026
Same journal

Tracking interstitial lung disease in systemic sclerosis: integrating lung magnetic resonance imaging into a clinically oriented multimodal follow-up strategy.

Clinical and experimental rheumatology·2026
See all related articles

Combination therapy for rheumatoid arthritis showed modest benefits before 1990, with improved erythrocyte sedimentation rates. However, trials were small, and drug combinations often led to increased toxicity, necessitating further research into safer, more effective regimens.

Area of Science:

  • Rheumatology
  • Pharmacology

Background:

  • Combination therapy, using multiple slow-acting antirheumatic drugs, is a strategy for treating rheumatoid arthritis.
  • Early research on combination therapy for rheumatoid arthritis was limited before 1990.

Purpose of the Study:

  • To provide a historical context for combination therapy in rheumatoid arthritis.
  • To evaluate studies on rheumatoid arthritis combination therapy conducted before 1990.

Main Methods:

  • A review of 11 published studies on rheumatoid arthritis combination therapy from 1980-1990.
  • Studies included randomized controlled trials, non-randomized parallel group studies, observational open studies, and retrospective reviews.
  • A total of 486 patients were analyzed across the included studies.

Related Experiment Videos

Main Results:

  • Common drug combinations included penicillamine with hydroxychloroquine/chloroquine, gold with hydroxychloroquine, and sulphasalazine with penicillamine.
  • Six studies reported positive outcomes, three suggested potential benefits, and two randomized controlled trials yielded negative findings.
  • An average erythrocyte sedimentation rate reduction of 21.4% was observed, but most studies indicated increased adverse events.

Conclusions:

  • By 1990, evidence suggested a modest advantage for combination therapy in rheumatoid arthritis, despite trial limitations.
  • Toxicity concerns arose, particularly with gold or penicillamine combinations.
  • Future advancements require identifying optimal drug combinations and conducting larger, well-designed trials.